Penn Medicine Provider
Mindy G. Schuster, MD, MSCE
Make an appointmentCall 800-789-7366

About me

  • Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Yale University
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Schuster is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Young JH, Ardura MI, Arrieta A, Bow EJ, Chandrasekar PH, Chen SC, Hammond SP, Husain S, Koo S, Laveren V, Nguyen MH, Patterson TF, So M, Thompson GR, Morrissey O, Schuster MG Modeling Invasive Aspergillosis Risk for the Application of ProphylaxisStrategies , Open Forum Infectious Disease, in press: 2024

Ohaly RA, Benoit ME, Schuster MG Infectious Diseases: What you may have missed in 2022 , Annals of Internal Medicine , 176(5): 2023,701-717

Freyer CW, Carulli A, Gier S, Ganetsky A, Timlin C, Schuster M, et al Letermovir vs high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical of mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide , Leukemia and Lymphoma: 2022

Minehart JC, Catania C, Perry L, Martin ME, Smith J, McCurdy SR, Pratz KW, Luger SM, Timlin C, Perl AE, Schuster M et al. Incidence and predictors of Sars-Cov-2 antibody responses following COVID-19 vaccination in allogeneic stem cell transplant recipients. , Blood 138 (S1)2888. 2021, 138: 2021,2888

Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG4 Stadtmauer EA5 Loren AW. Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. , American Journal of Hematology: 2020

Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Letourneau AR, Marty F, Nagel J, Najdzinowicz M, Saul M, Schuster M, Shohan S, Silveira F, Varughese C, Wilck M, Weatherby L, Van Oene J, Walker AM Long-term risk of hepatocellular carcinoma mortality in 23,220 hospitalized patients treated with micafungin or other parenteral antifungals , J Antimicrob Chemother : 2019,pii: dkz39

Ganetsky A, Han, JH, Hughes ME, Babushok DV Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Magan JM, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients , Clin Infect Dis, 68(12): 2019,2003-2009

Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, Dubberke ER, Husain S, Paterson D, Chiller T, Pappas P Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection Study: a Multi-Year, Multi-Center Prospective Cohort Study , Transpl Infect Dis: 2018,e12877

Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients , Transpl Infect Dis: 2018,e12855

Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Bene K Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study , Open Forum Infect Dis, 4(2): 2017,ofx050